103351058
reacted to
$Intuitive Machines (LUNR.US)$ 22m float. Stocks on worldwide news. Itll open around $14. Retail shorts will probably want to close their positions. Lets rocks and roll.
6
103351058
commented on
$Intuitive Machines (LUNR.US)$ Is this a potential stock?
Translated
1
2
103351058
commented on
$60 Degrees Pharmaceuticals (SXTP.US)$ buy now this at discount, FDA meeting is coming up. If we get +ve news from FDA then it can sky rocket 🚀🚀🚀.
2
1
$Infobird Software (IFBD.US)$ The partnership reflects Infobird's focus on advancing SaaS technologies and expanding into call center SaaS for business growth….definitely a good one to buy
2
$Nxu Inc (NXU.US)$ crct time to enter?
103351058
commented on
$CSI Compressco (CCLP.US)$
Today's Top Stock to Watch based on 20 Day Moving Avg Crossover: $CCLP
Entry: $2.02
This stock is at the beginning of an upward trend. PLEASE check volume and momentum before taking a position.
Today's Top Stock to Watch based on 20 Day Moving Avg Crossover: $CCLP
Entry: $2.02
This stock is at the beginning of an upward trend. PLEASE check volume and momentum before taking a position.
2
1
1
103351058
reacted to
Last week’s PDUFAs:
$Arcutis Biotherapeutics (ARQT.US)$ : Approved 12/15
• ZORYVE® (Roflumilast foam 0.3%)
⇒ topical foam
⇒ PDUFA: 12/16/23
⇒ NDA
⇒ Seborrheic dermatitis
$Merck & Co (MRK.US)$ : Approved 12/15
• KEYTRUDA (pembrolizumab) + Padcev (enfortumab vedotin-ejfv)
⇒ IV injection
⇒ PDUFA: 05/09/24
⇒ sBLA
⇒ Urothelial cancer
$Glaukos (GKOS.US)$ : Approved 12/14
• iDose® TR (travoprost)
⇒ intracameral implant
⇒ PDUFA: 12/22/23
⇒ NDA
⇒ Glaucoma
$Merck & Co (MRK.US)$ : Approved ...
$Arcutis Biotherapeutics (ARQT.US)$ : Approved 12/15
• ZORYVE® (Roflumilast foam 0.3%)
⇒ topical foam
⇒ PDUFA: 12/16/23
⇒ NDA
⇒ Seborrheic dermatitis
$Merck & Co (MRK.US)$ : Approved 12/15
• KEYTRUDA (pembrolizumab) + Padcev (enfortumab vedotin-ejfv)
⇒ IV injection
⇒ PDUFA: 05/09/24
⇒ sBLA
⇒ Urothelial cancer
$Glaukos (GKOS.US)$ : Approved 12/14
• iDose® TR (travoprost)
⇒ intracameral implant
⇒ PDUFA: 12/22/23
⇒ NDA
⇒ Glaucoma
$Merck & Co (MRK.US)$ : Approved ...
7
1
2
3
1